Nitric oxide inhibition of transforming growth factor-β and collagen synthesis in mesangial cells

Diabetes

Volumn 46, Issue 4, 1997, Pages 671-681

  Craven, Patricia A ^a,d   Studer, Rebecca K ^a   Felder, Jill ^a   Phillips, Stephen ^b,c   DeRubertis, Frederick R ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BISINDOLYLMALEIMIDE; CAPTOPRIL; COLLAGEN; CYCLIC GMP; CYCLIC GMP DERIVATIVE; GLUCOSE; INTERLEUKIN 1BETA; MESSENGER RNA; N ACETYL S NITROSOPENICILLAMINE; N(G) METHYLARGININE; NITRIC OXIDE; PHORBOL DIBUTYRATE; PROTEIN KINASE C; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CATTLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; ENZYME ACTIVITY; GLOMERULUS CAPILLARY; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

EID: 0030902095     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.46.4.671     Document Type: Article

References (62)

1. Craven PA, Studer RK, DeRubertis FR: Impaired NO-dependent cyclic GMP generation in glomeruli from diabetic rats: evidence for protein kinase C mediated suppression of the cholinergic response. J Clin Invest 93:311-320, 1994
2. Wang Y-X, Brooks DP, Edwards RM: Attenuated glomerular cGMP production and renal vasodilation in streptozotocin-induced diabetic rats. Am J Physiol 264:R952-R956,1993
3. Craven PA, Studer RK, DeRubertis FR: Impaired nitric oxide release by glomeruli from diabetic rats. Metabolism 44:695-698, 1995
4. Studer RK, Craven PA, DeRubertis FR: Thromboxane stimulation of mesangial cell fibronectin synthesis is signalled by protein kinase C and modulated by cGMP. Kidney Int 46:1074-1082, 1994
5. Tesfamariam B: Free radicals in diabetic endothelial dysfunction. Free Radical Biol Med 16:383-391, 1994
6. Diederich D, Skopec J, Diederich A, Dai F-X: Endothelial dysfunction in mesenteric resistance arteries of diabetic rats: role of free radicals. Am J Physiol 266:H1153-H1161, 1994
7. Elliott TG, Cockcroft JR, Groop PLT, Viberti GC, Ritter JM: Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin Sci (Colch) 85:687-693, 1993
8. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA: Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 97:22-28, 1996
9. Ayo SH, Radnik R, Garoni J, Troyer DA, Kreisberg JI: High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures. Am J Physiol 261:F571-F577, 1991
10. Studer RK, Craven PA, DeRubertis FR: Role for protein kinase C in the mediation of increased fibronectin accumulation by mesangial cells grown in high glucose medium. Diabetes 42:118-126, 1993
11. Fumo P, Kuncio GS, Ziyadeh FN: PKC and high glucose stimulate collagen α1(IV) transcriptional activity in a reporter mesangial cell line. Am J Physiol 267:F632-F638,1994
12. Ziyadeh FN, Sharma K, Ericksen M, Wolf G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor β. J Clin Invest 93:536-542, 1994
13. Studer RK, Craven PA, DeRubertis FR: Low density lipoprotein stimulation of mesangial cell fibronectin synthesis: role of protein kinase C and transforming growth factor β. J Lab Clin Med 125:86-95, 1995
14. Negrete H, Studer RK, Craven PA, De Rubertis FR: Role for transforming growth factor β in thromboxane-induced increases in mesangial cell flbronectin synthesis. Diabetes 44:335-339,1995
15. Studer RK, Negrete H, Craven PA, DeRubertis FR: Protein kinase C signals thromboxane induced increases in fibronectin synthesis and TGFβ bioactivity in mesangial cells. Kidney Int 48:422-430, 1995
16. Kagami S, Border WA, Mille DE, Noble NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor β expression in rat glomerular mesangial cells. J Clin Invest 93:2431-2437, 1994
17. Homma T, Akai Y, Burns KD, Harris RC: Activation of S6 kinase by repeated cycles of stretching and relaxation in rat glomerular mesangial cells: evidence for involvement of protein kinase C. J Biol Chem 267:23129-23135,1992
18. Studer RK, DeRubertis FR, Craven PA Nitric oxide suppresses increases in mesangial cell protein kinase C, transforming growth factor β, and fibronectin synthesis induced by thromboxane. J Am Soc Nephrol 7:999-1005,1996
19. Craven PA, Davidson CM, DeRubertis FR: Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipids. Diabetes 39:667-674,1990
20. Gopalkrishna R, Chen ZH, Gundimeda U: Nitric oxide and nitric oxide-generating agents induce a reversible inactivation of protein kinase C activity and phorbol ester binding. J Biol Chem 268:27180-27185, 1993
21. Marsden PA, Brock TA, Ballermann BJ: Glomerular endothelial cells respond to calcium-mobilizing agonists with release of EDRF. Am J Physiol 258:F1295-F1303, 1990
22. Mene P, Simonson MS, Dunn MJ: Physiology of the mesangial cell. Physiol Rev 69:1347-1423, 1989
23. 125I] labelled low density lipoprotein. Biochim Biophys Acta 620:631-635, 1980
24. Peterkofsky B, Diegelmann R: Use of a mixture of proteinase free collagenases for the specific assay of radioactive collagen in the presence of other proteins. Biochemistry 10:988-994,1971
25. Craven PA, DeRubertis FR: Protein kinase C is activated in glomeruli from streptozotocin diabetic rats: possible mediation by glucose. J Clin Invest 83:1667-1675,1989
26. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate phenol chloroform extraction. Anal Biochem 162:156-160, 1987
27. Danne T, Spiro J, Spiro RG: Effect of high glucose on type IV collagen production by cultured glomerular epithelial, endothelial, and mesangial cells. Diabetes 42:170-177, 1993
28. Pugliese G, Pricci F, Pugliese F, Mene P, Lenti L, Andreani D, Galli G, Casini A, Bianchi S, Rotella CM, DiMario U: Mechanisms of glucose-enhanced extra-cellular matrix accumulation in rat glomerular mesangial cells. Diabetes 43:478-490,1994
29. Stamler JS: Redox Signaling: nitrosylation and related target interactions of nitric oxide. Cell 78:931-936, 1994
30. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F, Duhamel L, Charon D, Kirilovsky J: The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266:15771-15781, 1991
31. Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, Gruetter CA: Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 218:739-749, 1981
32. Corbett JA, Tilton RG, Chang K, Hasan KS, Ido Y, Wang JL, Sweetland MA, Lancaster JR Jr, Williamson JR, McDaniel ML: Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41:552-556,1992
33. Pilz RB, Suhasini M, Idriss S, Meinkoth JL, Boss GR: Nitric oxide and cGMP analogs activate transcription from AP-1-responsive promoters in mammalian cells. FASEB J 9:552-558, 1995
34. Kim S-J, Angel P, Lafyatis R, Hattori K, Kim KY, Sporn MB, Karin M, Roberts AB: Autoinduction of transforming growth factor β1 is mediated by the AP-1 complex. Mol Cell Biol 10:1492-1497, 1990
35. Curran RD, Ferrari FK, Kispert PH, Stadler J, Stuehr DJ, Simmons RL, Billiar TR: Nitric oxide and nitric oxide generating compounds inhibit hepatocyte protein synthesis. FASEB J 5:2085-2092, 1991
36. Kunz D, Muhl H, Walker G, Pfeilschifter J: Two distinct signaling pathways trigger the expression of inducible nitric oxide synthase in rat renal mesangial cells. Proc Natl Acad Sci USA 91:5387-5391,1994
37. Trachtman H, Futterweit S, Singhai P: Nitric oxide modulates the synthesis of extracellular matrix proteins in cultured rat mesangial cells. Biochem Biophys Res Commun 207:120-125,1995
38. Taskiran D, Stefanovic-Racic M, Georgescu H, Evans C: Nitric oxide mediates suppression of cartilage proteoglycan synthesis by II-1. Biochem Biophys Res Commun 200:142-148,1994
39. Sekhar KR, Hatchett RJ, Shabb JB, Wolfe L, Francis SH, Wells JN, Jastorff B, Butt E, Chakinala MM, Corbin JD: Relaxation of PIg coronary arteries by new and potent cGMP analogs that selectively activate type I α compared with type Iβ cGMP dependent protein kinase. Mol Pharm 42:103-108, 1992
40. 2+ current modulated by cGMP-dependent protein kinase. Nature 369:336-339, 1994
41. Tsukahara H, Gordienko DV, Goligorsky MS: Continuous monitoring of nitric oxide release from human umbilical vein endothelial cells. Biochem Biophys Res Commun 193:722-729, 1993
42. Wiemer G, Scholkens BA, Becker RHA, Busse R: Ramiprilate enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension 18:558-563, 1991
43. Bank N, Aynedjian HS: Role of EDRF (nitric oxide) in diabetic renal hyper-filtration. Kidney Int 43:1306-1312, 1993
44. Tolins JP, Shultz PJ, Raij L, Brown DM, Mauer SM: Abnormal renal hemodynamic response to reduced renal perfusion pressure in diabetic rats: role of NO. Am J Physiol 265:F886-F895, 1993
45. Corbett JA, Tilton RG, Chang K, Hasan KS, Ido Y, Wang JL, Sweetland MA, Lancaster JR, Wlliamson JR, McDaniel ML: Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41:552-556, 1992
46. Tilton RG, Chang K, Hasan KS, Smith SR, Petrash JM, Misko TP, Moore WM, Currie MG, Corbet JA, McDaniel ML, Williamson JR: Prevention of diabetic vascular dysfunction by guanidines: inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes 42:221-232, 1993
47. Arima S, Ito S, Omata K, Takeuchi K, Abe K: High glucose augments angiotensin II action by inhibiting NO synthesis in in vitro microperfused rabbit afferent arterioles. Kidney Int 48:683-689, 1995
48. Graier WF, Wascher TC, Lackner L, Toplak H, Kreis GJ, Kukovetz WR: Exposure to elevated D glucose concentrations modulates vascular endothelial cell vasodilatory response. Diabetes 42:1497-1505, 1993
49. Baylis C, Mitruka B, Deng A: Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 90:278-281, 1992
50. Reyes AA, Karl IE, Kissane J, Klahr S: L-arginine administration prevents glomerular hyperfiltration and decreases proteinuria in diabetic rats. J Am Soc Nephrol 4:1039-1045, 1993
51. Reyes AA, Purkerson ML, Karl I, Klahr S: Dietary supplementation with L-arginine ameliorates the progression of renal disease in rats with subtotal nephrectomy. Am J Kidney Dis 20: 168-176, 1992
52. Katoh T, Takahashi K, Klahr S, Reyes AA, Badr KF: Dietary supplementation with L-arginine ameliorates glomerular hypertension in rats with subtotal nephrectomy. J Am Soc Nephrol 4:1690-1694, 1994
53. Fujihara CK, DeNucci G, Zatz R: Chronic nitric oxide synthesis inhibition aggravates glomerular injury in rats with subtotal nephrectomy. J Am Soc Nephrol 5:1498-1507, 1995
54. Simons JL, Provoost AP, Anderson S, Rennke HG, Troy JL, Brenner BM: Modulation of glomerular hypertension defines susceptibility to progressive glomerular injury. Kidney Int 46:396-404, 1994
55. Shultz P, Ray L: Endogenously synthesized nitric oxide prevents endotoxininduced glomerular thrombosis. J Clin Invest 90:1718-1725, 1992
56. Garg U, Hassid A: Inhibition of rat mesangial cell mitogenesis by nitric oxide generating vasodilators. Am J Physiol 257:F60-F66, 1989
57. Westendorp RGJ, Draijer R, Meinders AE, Van Hinsbergh VWM: Cyclic GMP mediated decrease in permeability of human umbilical and pulmonary artery endothelial cell monolayers. J Vasc Res 31:42-51, 1994
58. Kubes P, Granger DN: Nitric oxide modulates microvascular permeability. Am J Physiol 262:H611-H615, 1992
59. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA: Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc Natl. Acad Sci USA 90:1814-1818, 1993
60. Shankland SJ, Scholey JW: Expression of transforming growth factor β1 during diabetic renal hypertrophy. Kidney Int 46:430-442, 1994
61. Sharma K, Guo J, Jin Y, Ericksen M, Ziyadeh FN: Anti TGFβ antibody attenuates renal hypertrophy and matrix expression in diabetic mice (Abstract). J Am Soc Nephrol 5:972, 1994
62. Steffes MW, Osterby R, Chavers B, Mauer SM: Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 38:1077-1081, 1989